About
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated research and development company focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic tests. AXIM’s mission is to improve the life of patients worldwide through the development and commercialization of diagnostic solutions for a variety of medical conditions. AXIM owns two of the five FDA Cleared Diagnostic tests for Dye Eye Disease. Beyond AXIM’s ophthalmological solutions, AXIM has worked extensively on other diagnostic tools in the areas of ophthalmology and the program is ongoing. In addition to its FDA-cleared tests and on-going research, AXIM is working with clients across the country on development of new and innovative diagnostic solutions.